Evidence map›Paper›PMID 35741204›Full record

ArticleDiagnostics (Basel, Switzerland)2022

Bronchoalveolar Lavage as a Diagnostic Tool in an Atypical Pulmonary Langerhans Cell Histiocytosis.

Ovidiu Fira-Mladinescu, Noemi Suppini, Gheorghe-Emilian Olteanu, Corneluta Fira-Mladinescu, Daniel Traila

Open access · goldAbstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Ovidiu Fira-MladinescuCenter for Research and Innovation in Personalised Medicine of Respiratory Diseases, XIIIth Department-Pulmonology Discipline, "Victor Babes" University of Medicine and Pharmacy Timisoara, Eftimie Murgu Sq. no. 2, 300041 Timișoara, Romania.ORCID 0000-0002-9034-5218
Noemi SuppiniCenter for Research and Innovation in Personalised Medicine of Respiratory Diseases, XIIIth Department-Pulmonology Discipline, "Victor Babes" University of Medicine and Pharmacy Timisoara, Eftimie Murgu Sq. no. 2, 300041 Timișoara, Romania.
Gheorghe-Emilian OlteanuCenter for Research and Innovation in Personalised Medicine of Respiratory Diseases, XIIIth Department-Pulmonology Discipline, "Victor Babes" University of Medicine and Pharmacy Timisoara, Eftimie Murgu Sq. no. 2, 300041 Timișoara, Romania.ORCID 0000-0001-5921-4634
Corneluta Fira-MladinescuResearch Centre in Preventive Medicine, XIVth Department-Hygiene Discipline, "Victor Babes" University of Medicine and Pharmacy Timisoara, Eftimie Murgu Sq. no. 2, 300041 Timișoara, Romania.
Daniel TrailaCenter for Research and Innovation in Personalised Medicine of Respiratory Diseases, XIIIth Department-Pulmonology Discipline, "Victor Babes" University of Medicine and Pharmacy Timisoara, Eftimie Murgu Sq. no. 2, 300041 Timișoara, Romania.
Victor Babeș University of Medicine and Pharmacy Timișoara · RO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pulmonary Langerhans cell histiocytosis (PLCH) is an uncommon diffuse cystic lung disease that occurs almost exclusively in young adult smokers. High-resolution computed tomography of the chest allows a confident diagnosis of PLCH in typical presentation, when nodules, cavitating nodules, and cysts coexist and show a predominance for the upper and middle lung. Atypical presentations require histology for diagnosis. Histologic diagnosis rests on the demonstration of increased numbers of Langerhans cells and/or specific histological changes. PLCH is one of the few diseases in which bronchoalveolar lavage (BAL) has a high diagnostic value and can in some circumstances replace lung biopsy. We present a case of PLCH in an elderly non-smoker. Chest imaging revealed the presence of advanced interstitial lung disease with a fibrocystic pattern. BAL cellular analyses disclosed a macrophage pattern with CD1a phenotype that strongly supports the PLCH diagnosis, even in the setting of atypical clinical presentation and a lack of smoking exposure. PLCH is extremely rare in non-smokers and could represent a distinct phenotype.

Indexed as

cytopathologic diagnosisimmunohistochemical cell blocksmultiple cystic lung disease

Identifiers

PMID35741204
PMCPMC9221967
OpenAlexW4281741702

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.